Author:
Ni Wentao,Han Yuliang,Zhao Jin,Cui Junchang,Wang Kai,Wang Rui,Liu Youning
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Donadello, K., Scolletta, S., Covajes, C. & Vincent, J. L. suPAR as a prognostic biomarker in sepsis. BMC Med. 10, 2 (2012).
2. Thuno, M., Macho, B. & Eugen-Olsen, J. suPAR: the molecular crystal ball. Dis Markers. 27, 157–172 (2009).
3. Sier, C. F. et al. Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest. 79, 717–722 (1999).
4. Sandquist, M. & Wong, H. R. Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Rev Clin Immunol. 10, 1349–1356 (2014).
5. Toldi, G. et al. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission. Clin Chem Lab Med. 51, 327–332 (2013).
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献